GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Baskhanbiopharma Inc (XKRX:354390) » Definitions » Tax Expense

Baskhanbiopharma (XKRX:354390) Tax Expense : ₩-27 Mil (TTM As of Dec. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Baskhanbiopharma Tax Expense?

Baskhanbiopharma's tax expense for the six months ended in Dec. 2024 was ₩-27 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-27 Mil.


Baskhanbiopharma Tax Expense Historical Data

The historical data trend for Baskhanbiopharma's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Baskhanbiopharma Tax Expense Chart

Baskhanbiopharma Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24
Tax Expense
-440.00 - - -1,515.76 -26.63

Baskhanbiopharma Semi-Annual Data
Dec20 Dec21 Dec22 Dec23 Dec24
Tax Expense -440.00 - - -1,515.76 -26.63

Baskhanbiopharma Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Tax Expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₩-27 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Baskhanbiopharma  (XKRX:354390) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Baskhanbiopharma Tax Expense Related Terms

Thank you for viewing the detailed overview of Baskhanbiopharma's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Baskhanbiopharma Business Description

Traded in Other Exchanges
N/A
Address
354 Wondang-ro, Wongok-myeon, Anseong-si, Gyeonggi-do, KOR
Baskhanbiopharma Inc manufactures and distributes prescription drugs, over the counter drugs, medical devices and other related products.

Baskhanbiopharma Headlines

No Headlines